InvestSMART

Anax Metals Limited (ASX: ANX) - Announcements

- Current share price for ANX : $0.029

ASX company news and announcements for Anax Metals Limited (ANX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Anax Metals Limited (ANX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Anax Metals Limited (ANX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Anax Metals Limited (ANX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$51 Anadis Licenses Antibody Technologies from ImmuCell 12 Mar 2008 10:55AM $0.081 $0.029 fallen by 64.20%
$51 Reinstatement to Official Quotation 11 Mar 2008 2:45PM $0.081 $0.029 fallen by 64.20%
$51 Launches Products to Reduce Global Childhood Diarrhea Deaths 11 Mar 2008 2:26PM $0.081 $0.029 fallen by 64.20%
$51 Suspension from Official Quotation 6 Feb 2008 10:14AM n/a $0.029 n/a
$51 Trading Halt 4 Feb 2008 2:28PM n/a $0.029 n/a
$51 Anadis and SPC Ardmona Solidify Healthy Food Collaboration 29 Jan 2008 12:18PM n/a $0.029 n/a
$51 Milk-based Anti-influenza antibodies to provide immunity 9 Jan 2008 10:22AM $0.145 $0.029 fallen by 80%
$51 Anadis and Hadasit to Form JV for diseases including Cancer 14 Nov 2007 3:08PM $0.105 $0.029 fallen by 72.38%
$51 Travelan South Africa 4 Sep 2007 10:47AM $0.155 $0.029 fallen by 81.29%
$51 Appendix 4E 31 Aug 2007 2:11PM $0.130 $0.029 fallen by 77.69%
$51 Anadis Capital Raising 31 Aug 2007 11:17AM $0.145 $0.029 fallen by 80%
$51 Jump in functional food revenue 16 Aug 2007 10:51AM $0.160 $0.029 fallen by 81.88%
$51 Anadis to use its Polyclonal Antibodies 10 Aug 2007 2:15PM $0.160 $0.029 fallen by 81.88%
$51 Anadis and ImmuCell to Cross-license Antibody Technologies 6 Aug 2007 12:38PM $0.165 $0.029 fallen by 82.42%
$51 Standby Subscriptions Agreement 18 Jun 2007 10:45AM $0.185 $0.029 fallen by 84.32%
$51 Expand Clinical Trial for Inflammatory Bowel Disease 7 Jun 2007 11:04AM $0.200 $0.029 fallen by 85.50%
$51 Signs HOA with SPC Ardmona Ltd 4 Jun 2007 10:34AM $0.210 $0.029 fallen by 86.19%
$51 $480k Government Grant 23 May 2007 9:30AM $0.185 $0.029 fallen by 84.32%
$51 Sale & Lease back of Premises 12 Apr 2007 2:18PM $0.230 $0.029 fallen by 87.39%
$51 To Pursue Project Ectoplasm 22 Mar 2007 11:04AM n/a $0.029 n/a
$51 Final EV-71 Antibodies Highly Effective 20 Mar 2007 2:28PM $0.235 $0.029 fallen by 87.66%
$51 Half Yearly Report/Half Year Accounts 28 Feb 2007 6:10PM n/a $0.029 n/a
$51 To establish US Subsidiary 17 Jan 2007 9:46AM $0.320 $0.029 fallen by 90.94%
$51 Successfully raises Flu Antibodies 14 Dec 2006 10:24AM $0.270 $0.029 fallen by 89.26%
$51 Trial for Ulcerative Colitis Commences 30 Nov 2006 2:07PM $0.250 $0.029 fallen by 88.40%

451 - 475 of 504 results

Page 19 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.